Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Rani Therapeutics director, 10% owner Mir A. Imran buys 36,000 shares worth $24,840

Rani Therapeutics director, 10% owner Mir A. Imran buys 36,000 shares worth $24,840

ReutersReuters2026/07/23 20:11
By:Reuters
  • Rani Therapeutics director Mir A Imran bought 36,000 Class A shares at $0.69, lifting his directly held stake to 2,119,334 shares.
  • He also reported indirect ownership of 74,139 Class A shares.
  • Indirect holdings included 22,660,053 Class B shares.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rani Therapeutics Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001031686-26-000006), on July 23, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!